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ABSTRACT
Cas9 is an RNA-guided endonuclease in the bacterial
CRISPR–Cas immune system and a popular tool for
genome editing. The commonly used Streptococcus
pyogenes Cas9 (SpCas9) is relatively non-specific
and prone to off-target genome editing. Other Cas9
orthologs and engineered variants of SpCas9 have
been reported to be more specific. However, previ-
ous studies have focused on specificity of double-
strand break (DSB) or indel formation, potentially
overlooking alternative cleavage activities of these
Cas9 variants. In this study, we employed in vitro
cleavage assays of target libraries coupled with high-
throughput sequencing to systematically compare
cleavage activities and specificities of two natural
Cas9 variants (SpCas9 and Staphylococcus aureus
Cas9) and three engineered SpCas9 variants (Sp-
Cas9 HF1, HypaCas9 and HiFi Cas9). We observed
that all Cas9s tested could cleave target sequences
with up to five mismatches. However, the rate of
cleavage of both on-target and off-target sequences
varied based on target sequence and Cas9 variant.
In addition, SaCas9 and engineered SpCas9 variants
nick targets with multiple mismatches but have a de-
fect in generating a DSB, while SpCas9 creates DSBs
at these targets. Overall, these differences in cleav-
age rates and DSB formation may contribute to varied
specificities observed in genome editing studies.
INTRODUCTION
Cas9 is the well-studied effector protein of type II CRISPR–
Cas (clustered regularly interspaced short palindromic
repeats-CRISPR associated) bacterial immune systems
(1,2). Cas9 is an endonuclease that uses a dual CRISPR
RNA (crRNA) and trans-activating crRNA (tracrRNA) to
bind dsDNA targets that are complementary to the guide
region of the crRNA and adjacent to a short, conserved
protospacer-adjacent motif (PAM) sequence (3,4). Two nu-
clease domains in Cas9, HNH and RuvC, cut the target
and non-target strand respectively, generating a double-
stranded break (DSB) in the dsDNA (4) with little post-
cleavage trimming (5,6). The dual RNAs can be com-
bined into a single guide-RNA (sgRNA) and the target-
ing region can be varied, making Cas9-sgRNA a readily
programmable, two component system for use in various
biotechnological applications (4,7). In particular, DSB for-
mation followed by DNA repair can lead to changes in ge-
nomic DNA sequence, enabling genome editing following
Cas9 cleavage (8,9).
Cas9 can tolerate mismatches between the crRNA and
the target DNA, which is consistent with its role as a bac-
terial immune system effector in facilitating defense against
rapidly evolving bacteriophages (10–13). Cas9 generally tol-
erates multiple mismatches in the PAM-distal region while
PAM-proximal ‘seed’ mismatches reduce the cleavage ac-
tivity (14–18). This low fidelity leads to off-target activity
when used for genome editing applications, as Cas9 can cre-
ate DSBs at sites with limited homology to the intended
target (16,17,19). While the commonly used wildtype (WT)
Streptococcus pyogenes Cas9 (SpCas9) can tolerate multi-
ple mismatches in the target sequence, other naturally oc-
curring Cas9 orthologs from Staphylococcus aureus, Neis-
seria meningitidis and Campylobacter jejuni are reported to
have higher specificity in genome editing compared to Sp-
Cas9 (20–23). Many other strategies have been developed
to reduce off-target activity of Cas9 (24). SpCas9 has been
engineered to improve the fidelity of target cleavage activity.
Some mutations were designed to reduce DNA target inter-
actions, making the requirement for complete complemen-
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tarity with the crRNA more stringent (25,26). Mutations
rationally introduced in the REC domain of SpCas9 pre-
vent conformational changes required for nuclease domain
activation when a target sequence with mismatches is en-
countered (27,28). Bacterial screens have also been used to
select high-fidelity SpCas9 variants that maintain on-target
cleavage but have reduced off-target cleavage activity (29–
31).
Several methods have been developed to detect and study
off-target activities of Cas9 (24,32–35). However, methods
that measure Cas9 off-target editing in eukaryotic cells are
limited because cellular factors like nucleosomes may se-
quester potential cleavage sites (36,37). DNA accessibility
can also vary depending on cellular processes, which may
change the outcome and detection of potential Cas9 off-
target editing events. These methods also rely on DSBs in
the DNA generated by Cas9 or post-cleavage DNA repair
and indel formation, which can vary among cell types and
experiments (24,32–35). Differences in Cas9/sgRNA deliv-
ery methods and cell lines have resulted in discrepancies
in the reported specificities of high-fidelity Cas9 variants
(25,27,31,35).
To avoid these pitfalls, specificity studies can be per-
formed in vitro to detect the native cleavage activities of
Cas9 variants (6,14,15,18,38–41). Here, we used a previ-
ously established in vitro plasmid library cleavage assay to
compare the native cleavage specificity of different Cas9
variants (42). Our method enables the detection of target
sequences that may be incompletely cleaved by Cas9, lead-
ing to nicking. We tested the cleavage activity of two WT
Cas9 orthologs, SpCas9 and S. aureus Cas9 (SaCas9), and
three engineered SpCas9 variants, SpCas9 HF1 (25), hyper-
accurate Cas9 (HypaCas9) (27) and Alt-R® S.p. HiFi Cas9
(31) against two different target library sequences. Each
of these three variants represent a version of high-fidelity
Cas9 developed via different strategies discussed above. We
show that SpCas9 rapidly cleaves target sequences with up
to five mismatches. While the high-fidelity Cas9 variants re-
tained cleavage activity against targets with multiple mis-
matches, they have reduced rates of cleavage compared to
SpCas9. High-fidelity Cas9 variants also nick target se-
quences with multiple mismatches, resulting in incomplete
DSB formation at sites that are fully cleaved by wild-type
SpCas9. Overall, our study reveals a target-sequence depen-
dent nicking defect of high-fidelity Cas9 variants that may
account for increased specificity observed in genome editing




Expression plasmids for SpCas9 and high-fidelity variants
were purchased from Addgene. Streptococcus pyogenes
Cas9 (SpCas9) (pMJ806) was expressed using expres-
sion plasmid pEC-K-MBP, and SpCas9-HF1 (pJSC111)
and HypaCas9 (pJSC173) were expressed using expres-
sion plasmid pCT10. pMJ806, pJSC111, pJSC173 were
gifts from Jennifer Doudna and/or Keith Joung (Ad-
dgene plasmid #39312; http://n2t.net/addgene:39312;
RRID:Addgene 39312; Addgene plasmid # 101209;
http://n2t.net/addgene:101209; RRID:Addgene 101209;
Addgene plasmid #101218; http://n2t.net/addgene:101218;
RRID:Addgene 101218). The gene sequence for S. au-
reus Cas9 (SaCas9) was synthesized as Escherichia coli
codon-optimized gBlocks (purchased from Integrated
DNA Technologies, IDT). SaCas9 gBlocks were cloned
into pSV272 with N-terminal 6X-His sequence, a maltose
binding protein (MBP) and a Tobacco Etch Virus (TEV)
protease cleavage site via Gibson assembly (New England
Biolabs) as per the manufacturer’s protocol. All sequences
were verified by Sanger sequencing (Eurofins Genomics,
Kentucky, USA).
Cas9 expression and purification
All Cas9 proteins were expressed in E. coli BL21 (DE3)
cells. Overnight cultures of the cells carrying the expres-
sion plasmid were used to inoculate 2× TY broth supple-
mented with corresponding antibiotics in 1:100 ratio. The
antibiotics used were kanamycin at 25 g/ml for SpCas9
(pMJ806), and at 50 g/ml for SaCas9 (pSV272 construct)
and ampicillin at 100 g/ml for SpCas9-HF1 (pJSC111)
and HypaCas9 (pJSC173). Cultures were grown at 37◦C to
an optical density (600 nm) of 0.5−0.6 and IPTG was added
to a final concentration of 0.2 mM to induce protein ex-
pression. The incubation was continued at 18◦C overnight
(∼16–18 h) and harvested the next day for protein purifica-
tion.
SpCas9 was purified using a previously established pro-
tocol (43). Cells were resuspended in Lysis Buffer I (20
mM Tris–HCl pH 8.0, 500 mM NaCl, 10 mM imidazole,
and 10% glycerol) supplemented with PMSF. A sonicator
was used to lyse the cells and the lysate was centrifuged
to remove insoluble material. The clarified lysate was ap-
plied to a HisPur™ Ni-NTA Resin (ThermoFisher Scien-
tific) column. After washing the column with Lysis Buffer
I, the bound protein was eluted in Elution Buffer I (Lysis
Buffer I + 250 mM imidazole final concentration). The Ni-
NTA column eluent was concentrated and run on a HiLoad
16/600 Superdex 200 gel filtration column (GE Healthcare)
pre-equilibrated with SEC Buffer A (20 mM Tris–HCl, pH
8.0, and 500 mM NaCl). TEV protease was added at 1:100
(w/w) ratio to the pools containing 6X His-MBP tagged
Cas9 and incubated on ice, overnight at 4◦C. Samples were
reapplied to HisPur™ Ni-NTA Resin (ThermoFisher Scien-
tific) to remove the His-tagged TEV, free 6X His-MBP, and
any remaining tagged protein. The flow-through was col-
lected, concentrated and further purified by using a HiLoad
16/600 S200 gel filtration column in SEC Buffer B (20 mM
Tris–HCl, pH 8.0, 200 mM KCl and 1 mM EDTA). Peak
pools were analyzed on SDS-PAGE gels and the pools with
Cas9 were combined, concentrated, flash frozen in liquid ni-
trogen and stored at −80◦C until further use. Cleavage ac-
tivity of SpCas9 purified using this protocol was similar to
commercially available SpCas9 (data not shown).
An alternative previously established purification proto-
col was used for all other Cas9 variants (44), with the excep-
tion of Alt-R® S.p. HiFi Cas9, which was provided by In-
tegrated DNA Technologies (IDT). Harvested cells were re-
suspended in Lysis Buffer II (20 mM Tris–HCl pH 8.0, 500
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inhibitors (PMSF, cOmplete™ Protease Inhibitor Cocktail
Tablet or Halt Protease Inhibitor Cocktail). A sonicator
was used to lyse the cells and the lysate was centrifuged
to remove insoluble material. The clarified lysate was ap-
plied to a HisPur™ Ni-NTA Resin (ThermoFisher Scien-
tific) column. After washing the column with 10 column
volumes of Wash Buffer (Lysis Buffer + 15 mM imidazole fi-
nal concentration), the bound protein was eluted in Elution
Buffer I (Lysis Buffer II + 250 mM imidazole final concen-
tration). Fractions containing Cas9 were pooled and TEV
protease was added in a 1:100 (w/w) ratio and dialyzed in
Dialysis Buffer (10 mM HEPES–KOH pH 7.5, 200 mM
KCl, 1 mM DTT) at 4◦C overnight. The dialyzed protein
was diluted 1:1 with 20 mM HEPES KOH (pH 7.5) and
loaded on a HiTrap Heparin HP (GE Healthcare) column
and washed with Buffer A (20 mM HEPES–KOH pH 7.5,
100 mM KCl). The protein was eluted with Buffer B (20 mM
HEPES–KOH pH 7.5, 2 M KCl) by applying a gradient
from 0% to 50% over a total volume of 60 ml. Eluted peak
fractions were analyzed by SDS-PAGE and fractions with
Cas9 were combined and concentrated. DTT was added to
a final concentration of 1 mM. The protein was fraction-
ated on a HiLoad 16/600 Superdex 200 gel filtration column
(GE Healthcare), eluting with SEC buffer (20 mM HEPES–
KOH pH 7.5, 500 mM KCl, 1 mM DTT). Peak pools were
analyzed on SDS-PAGE gels and the pools with Cas9 were
combined, concentrated, flash frozen in liquid nitrogen and
stored at −80◦C until further use.
Variations in Cas9 purification procedures could lead to
differences in activity of the Cas9 variants. However, the
level of purity was similar for all variants, and conditions
were identical for all reactions (Supplementary Figure S1A)
(see methods section––in vitro cleavage assay and analysis).
All Cas9s were frozen as high concentration stocks (∼61–
200 M). Working stock concentrations of the proteins (5
or 10 M) were made in SEC buffer (20 mM HEPES–KOH
pH 7.5, 500 mM KCl, 1 mM DTT).
Library creation
Target libraries were partially randomized to generate a
pool of sequences containing mismatches (45). The follow-
ing probability distribution function was used to determine
the randomization/doping frequency,
P (n, L, f ) = L!
n! (L − n)! ( f
n) (1 − f ) (L − n) (1)
where P is the pool of the population, L is the sequence
length, n is the number of mutations/template and f is
the probability of mutation/position (doping level or fre-
quency). A randomization/doping frequency (f) of 15% re-
sults in a library containing a mixed pool of sequences of 20
nt (L) with a high representation of two to four mismatches
(n). Single-stranded oligonucleotide libraries were ordered
from IDT using hand mixed pools (https://www.idtdna.
com/pages/products/custom-dna-rna/mixed-bases). For li-
braries with 15% randomization/doping frequency, if the
target sequence has A at a given position, a mix of A:C:G:T
would be dispensed in 85:5:5:5 ratio during oligonucleotide
synthesis resulting in 85% A at this position and 15% of C,
G or T (5% each).
The number of different mutation combinations (MMc)
for a given number of mutations, n, and sequence length,
L, regardless of the doping level/frequency is determined
by
MMc = 3n L!n! (L − n)! (2)
The total number of unique target sequences with a single
mismatch is 60, with two mismatches is 1710, and with three
mismatches is 30,780, etc. We used two library sequences
that we previously tested for Cas12a (42), a modified pro-
tospacer 4 (PS4) sequence from S. pyogenes CRISPR locus
(55% GC) and EMX1 gene target sequence (80% GC) (see
Supplementary Table S1 for target sequence).
Plasmid and nucleic acid preparation
All DNA oligonucleotides used in this study were syn-
thesized by IDT or Thermo Scientific. RNAs (tracrRNA
and crRNA) and single-stranded target or library oligonu-
cleotides were ordered from IDT. Supplementary Table S1
lists the sequences of DNA and RNA oligonucleotides used
in this study.
Gibson assembly was used to generate target (pTarget)
and library (pLibrary) plasmids (46). The oligonucleotides
for the targets or libraries were diluted to 0.2 M in
1× NEBuffer 2. pUC19 vector was amplified using primers
listed in Supplementary Table S1 via PCR to insert homol-
ogy arms. The PCR reaction was subjected to DpnI diges-
tion and PCR clean up (Promega Wizard SV Gel and PCR
Clean-Up System), as per the manufacturer’s protocol. 30
ng of PCR amplified pUC19, 5 l of oligonucleotide (0.2
M) and ddH2O to bring the volume to 10 l were mixed
with 10 l 2× NEBuilder HiFi DNA Assembly Master mix
(New England Biolabs) and incubated at 50◦C for 1 h. NEB
Stable competent cells were transformed with 2 l of the as-
sembled product, as per the manufacturer’s protocol. Trans-
formants were plated for plasmid preparation (for pTarget
plasmids) or to assess transformation efficiencies (for pLi-
brary plasmids). For pTarget, starter cultures from individ-
ual colonies were used to inoculate 50 ml LB media with
100 g/ml ampicillin. For pLibrary, all of cells in the out-
growth media from the transformation recovery were used
to inoculate 50 ml LB with 100 g/ml ampicillin. Cultures
were grown overnight at 37◦C for plasmid propagation and
extraction using QIAGEN Plasmid Midi Kit. The follow-
ing precautions were taken to ensure the plasmid remained
supercoiled during plasmid extractions. Cells were cooled
on ice before harvesting. All initial steps from lysis to neu-
tralization for plasmid extractions were performed on ice
with minimum mechanical stress. Plasmids were stored as
aliquots that were used for up to 10 freeze-thaw cycles. Dif-
ferent pLibrary assembly reactions and preparations were
used for the replicates of the in vitro cleavage assays (Sup-
plementary Figure S1B). All pTarget sequences were veri-
fied by Sanger sequencing (Eurofins Genomics, Kentucky,
USA). For controls, pUC19 was prepared by restriction en-
zyme digestion using BsaI-HF to linearize the plasmid and
Nt.BspQI to nick the plasmid using the manufacturer’s pro-
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In vitro cleavage assay and analysis
The protocol was adapted from previously described meth-
ods (47). Cas9:tracrRNA:crRNA complex was formed by
incubating Cas9 and tracrRNA:crRNA at a 1:1.5 ratio in
reaction buffer (20 mM HEPES, pH 7.4, 100 mM KCl, 5
mM MgCl2, 1 mM DTT and 5% glycerol) at 37◦C for 10
min. Cas9 RNP complex (final concentration 100 nM Cas9
and 150 nM tracrRNA:crRNA) was mixed with pTarget,
pLibrary or empty plasmid (15 ng/l, ∼9 nM) to initiate
cleavage reactions at 37◦C. Phenol–chloroform was used to
quench reaction aliquots at 5, 10, 15, 30, 60, 300 and 1800 s
for pTarget and at 1, 5, 30, 60 and 180 min for pLibrary. The
aqueous layer was extracted and separated on a 1% agarose
gel via electrophoresis and stained with SYBR Safe (Invit-
rogen) or RedSafe (Intron Bio) stain for dsDNA visualiza-
tion. Excess tracrRNA:crRNA was used in cleavage assays
to prevent any RNA-independent cleavage activity (48). All
cleavage assays were performed in triplicate.
Bands were visualized and quantified with ImageJ (https:
//imagej.nih.gov/ij/). Intensities of the band (I) in the un-
cleaved (supercoiled - SC) and cleaved fractions (nicked – N
and linearized – L) were measured. Fractions (FR) cleaved
and uncleaved were calculated as follows:
Fraction cleaved (FRC) = IN + ILISC + IN + IL (3)
Fraction uncleaved or supercoiled (FRSC)
= ISC
ISC + IN + IL (4)
Fraction nicked (F RN) = INISC + IN + IL (5)
Fraction linearized (FRL) = ILISC + IN + IL (6)
The FRSC, FRN and FRL were determined for each of the
time points ‘t’. FR for time point 0 (FR0) was determined
for the negative control pLibrary (i.e. pLibrary run on a gel
after preparation as represented in Supplementary Figure
S1B).
The apparent rates of pTarget and pLibrary cleavage were
determined by fitting FRC to a one-phase association equa-
tion using GraphPad Prism v 8.4.3 (https://www.graphpad.
com/scientific-software/prism/).
FR = FR0 + (FRfinal − FR0) (1 − e−kt) (7)
where t is time, FR is the appropriate FRc that starts from
FR0 and goes to FRfinal (FR at the last time point), and k is
the apparent rate constant.
Library preparation for HTS
Agarose gel electrophoresis (as described above) was used to
separate the plasmid library cleavage products into cleaved
(linear and nicked) and uncleaved (supercoiled) products.
The bands from the nicked and supercoiled pools from var-
ious time points were excised separately and were individ-
ually gel purified using QIAquick Gel Extraction Kit (Qi-
agen). Nextera Adapters (NEA) were designed to amplify
across the target region in the pLibrary. Because the PCR
primers amplified across the target region, Cas9-mediated
linearization of the plasmid due to DSB formation at the
target site did not yield any PCR product while Cas9 medi-
ated nicked plasmid resulted in amplification of the target
region via PCR. Standard Nextera unique indices/barcodes
were used to multiplex the samples and were added to the
first PCR products using another round of PCR (see Sup-
plementary Table S1 for NEA primers). Samples were pu-
rified using QIAquick PCR Purification Kit (Qiagen) be-
tween the two PCR steps. The size of the PCR products was
verified using Agilent 2100 Bioanalyzer. Pooled samples
were subjected to NextSeq or MiSeq for paired-end reads
of 75 cycles at Admera Health, LLC (New Jersey, USA) or
Iowa State DNA Facility (Ames, IA). Samples were pooled
and multiplexed to get an average of 100,000 reads per sam-
ple (Supplementary Figure S2D). To ensure coverage of
each sample in a minimal number of NextSeq/MiSeq runs,
we included two out of the three replicates performed for the
pLibrary cleavage assays. Fifteen percent PhiX was spiked
in to increase sequence diversity of the sample.
HTS data analysis
Extraction of target sequences, read counts, and num-
ber of mismatches per target sequence from HTS data
were analyzed using custom bash scripts (see associ-
ated GitHub repository: https://github.com/sashital-lab/
Cas9 specificity). A simple workflow of the analysis is de-
scribed in Supplementary Figure S3, adapted from our pre-
vious study on Cas12a (42). Target sequences were extracted
along with the counts of the extracted target sequences
and the number of mismatches. The files containing the ex-
tracted target sequences and counts are available on Iowa
State University Library’s DataShare (see Availability for
more information). Target sequence information was im-
ported into Microsoft Excel or R for plotting and summa-
rizing, post command-line processing.
In each pool, the fraction of target sequences containing
‘n’ mismatches (MM) (Fn-MM) was calculated as follows.
Fn-MM =
total counts of sequences with
n mismatches
total counts of all sequences in the pool
(8)
Fn-MM was normalized to the fraction (FR) of DNA
present in the supercoiled or nicked fraction at a given time
point ‘t’ to generate an estimated abundance (EA) of a given
set of sequences at a given timepoint. FR was calculated for
each time point using Equations (3) through (6) as described
above.
EAn-MM = (Fn-MM of S at t)∗ (FR at t) (9)
These values were plotted against number of mismatches
(n) to generate mismatch distribution curves.
The relative abundance (enrichment and/or depletion)
(RA) of a sequence containing ‘n’ mismatches at each time
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on a gel after preparation as represented in Supplementary
Figure S1B).
RAS = EAn-MM of S at tEAn-MM in pLibrary (10)
Log-fold change in abundance was calculated as in Equa-
tion (11) for each time point ‘t’ and plotted as a heatmap to
determine overall depletion or accumulation of targets con-
taining a certain number of mismatches.
Log-fold change in abundance = log2(RAS) at t (11)
The RA for the perfect target sequence (0 MM), RA0MM
was calculated using Equation (10), where n = 0 at the dif-
ferent time points. The RA for target sequences with 1 to 5
MM at each time point ‘t’, RA1–5MM-t was calculated by
summing EA for 1 to 5 MM, EA1–5MM at each time point,
and normalizing to the sum of EA of 1–5 MM in the nega-
tive control (i.e. pLibrary run on a gel after preparation as




EAn−MM of S at t
EAn−MM in pLibrary
(12)
The relative cleaved fraction of counts for on-target and
off-targets (RAcleaved FR) was determined by subtracting
RA0MM and RA1–5MM values, respectively from 1 at each
time point ’t’, as shown below and plotted against time.
RAcleaved FR-on-t = 1 − RA0MM−t (13)
RAcleaved FR-off-t = 1 − RA1−5MM−t (14)
The specificity score (SS) for Cas9 cleavage was calculated
by dividing the on-target by off-target RAcleaved FR at each
time point ‘t’.
SS = RAcleaved FR-on−t
RAcleaved FR-off−t
(15)
The specificity scores of SaCas9 and HF Cas9 variants
were normalized to WT SpCas9 to determine relative speci-
ficity at each time point.
For the heatmaps, the estimated abundance (EA) of se-
quences containing a particular nucleotide (N = A, G, C,
T) at a particular position (P = 1 to 20) for target sequences
containing ‘n’ mismatches at each time point ‘t’ was calcu-
lated as above. Relative abundance (RA) was calculated by
normalizing EA against the pool of DNA in the original li-
brary to eliminate variability in aberrant nicking that may
have occurred for individual pLibraries in the negative con-
trol.
RAS−NP
= EAn−MM of S with N at P at t
EAn-MM of S with N at P in pLibrary
(16)
For the supercoiled pool, we calculated the maximum
change in relative abundance (RA) over time as max
RAS-NP for each sequence containing a particular nu-
cleotide (N = A, G, C, T) at a particular position (P = 1 to
20) for target sequences containing ‘n’ mismatches over all
time points ‘t’ (0, 1, 5, 30, 60 and 180 min). Max RAS-NP is








For the nicked pool, we calculated the average change in
relative abundance (RA) over time as RAS-NP for each se-
quence containing a particular nucleotide (N = A, G, C, T)
at a particular position (P = 1 to 20) for target sequences
containing ‘n’ mismatches over time points ‘t’ after Cas9
cleavage (1, 5, 30, 60 and 180 min). RAS-NP is indicated








In the supercoiled pool, we defined the extent of
cleavage of a target sequence from the supercoiled pool
as abundancemin by determining the minimum value of
RAS-NP across all time points for those target sequences. For
the nicked pool, we defined the extent of nicking of a tar-
get sequence as abundancemax by determining the maximum
value of RAS-NP across all time points for those target se-
quences. Abundancemin or abundancemax were normalized
to the highest value across both pLibraries, Cas9s and mis-
matches (1 to 5 MM) which allows comparison between
Cas9s and mismatches. Using custom scripts in R, the 
abundance and abundancemin and abundancemax were used
to plot the bubble heatmaps for the supercoiled and nicked
pools, respectively.  max change and  abundance defined
the gradient color and abundancemin and abundancemax de-
fined the bubble size.
For the analysis of target sequences with two mismatches,
the sequences with two mismatches were extracted. The dis-
tance between the two mismatches and the total counts for
sequences separated by that distance were determined. The
counts were normalized to the number of possible ways the
two mismatches can occur (42), and the max  abundance,
 abundance, abundancemin and abundancemax were calcu-
lated similarly to Equations (16), (17) and (18) and plotted
versus distance between mismatches.
RESULTS
Cleavage activity of Cas9 against target library
We sought to compare the cleavage activity and specificity
of different Cas9 variants in a systematic manner. We per-
formed a previously established in vitro plasmid library
(pLibrary) cleavage assay with five Cas9 variants (42), WT
SpCas9, WT SaCas9 and three high-fidelity variants of
SpCas9–SpCas9 HF1, HypaCas9 and Alt-R® S.p. HiFi
Cas9 (HiFi Cas9) (Figure 1A, Supplementary Figure S1A)
(25,27,31). The three high-fidelity variants of SpCas9 will
be collectively referred to as HF Cas9 hereafter. For each
Cas9 variant, we used two different crRNA sequences with






/nar/advance-article/doi/10.1093/nar/gkab163/6179346 by guest on 30 M
arch 2021




Figure 1. Systematic in vitro analysis of Cas9 mismatch tolerance. (A) Outline and workflow of the in vitro pLibrary cleavage assay. (B, C) Overall cleavage
of pTarget and pLibrary (B) PS4 and (C) EMX1 by Cas9 plotted against time. Plot for pTarget shows appearance of linearized pool over time and plots for
pLibrary show the decrease in supercoiled (nSC) pool and appearance of nicked (n) and linear (li) pools over time. The 0 time point is the quantification
of the negative control pLibrary (i.e. pLibrary run on a gel after preparation as represented in Supplementary Figure S1B). The time points for pTarget
cleavage are 5 s, 10 s, 15 s, 30 s, 1 min, 5 min, 15 min and the time points for pLibrary cleavage are 1, 5, 30, 60 and 180 min. Values plotted represent an
average of three replicates for both pTarget and pLibrary. Error bars are SEM. *P < 0.05, Student’s t-test of for rates of cleavage of pTarget and pLibrary
compared to SpCas9. (D) Average accumulation of pLibrary nicked pool for Cas9 variants compared to SpCas9 over time. Values plotted represent an
average of three replicates. Error bars are SEM. *P < 0.05, Student’s t-test compared to SpCas9. Sa = SaCas9, HF1 = SpCas9 HF1, Hypa = HypaCas9,
HiFi = Alt-R® S.p. HiFi Cas9.
supercoiled (nSC) plasmids containing the perfect target
(pTarget) or target library (pLibrary) (see Materials and
Methods section – Plasmid and nucleic acid preparation)
(Supplementary Figure S1B). The pLibraries contained a
distribution of target sequences with between zero and ten
mismatches to the crRNA guide sequence, with a maxi-
mum representation of target sequences with two to four
mismatches in the libraries (Supplementary Figure S1C).
The two crRNA and library sequences were designed based
on protospacer 4 sequence from S. pyogenes CRISPR locus
(55% G/C) and EMX1 gene target sequence (80% G/C),
referred to as pLibrary PS4 and pLibrary EMX1 respec-
tively. We employed the native dual crRNA and tracrRNA
system for our assay to avoid any differences that may stem
from single guide RNA design optimization (49,50).
We used the differential migration of the nicked (n) and
linear (li) cleavage products of negatively supercoiled (nSC)
dsDNA plasmid on an agarose gel to analyze Cas9 cleav-
age activity (51) (Supplementary Figure S2A). Linear prod-
ucts represent fully cleaved DNA, in which both strands
were cleaved by Cas9. The accumulation of linear DNA
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get. Cleavage rates of pTarget were significantly variable de-
pending both on target sequence and Cas9 variant (Fig-
ure 1B, C, Supplementary Figure S2A, B). SpCas9 cleaved
pTarget PS4 ∼3.6-fold faster than pTarget EMX1. A simi-
lar trend was observed for SaCas9, although this ortholog
cleaved both pTargets ∼7-fold slower than SpCas9 (Fig-
ure 1B, C, Supplementary Figure S2A, B). Among the HF
Cas9s, HiFi Cas9 had cleavage rates that were comparable
to WT SpCas9. In contrast, SpCas9 HF1 and HypaCas9
cleaved pTarget PS4 ∼36- and ∼12-fold slower than Sp-
Cas9, respectively (Figure 1B, C, Supplementary Figure
S2B), similar to previously reported cleavage defects for
these two HF Cas9 variants (52). However, cleavage rates
for SpCas9 HF1 and HypaCas9 were comparable to Sp-
Cas9 for pTarget EMX1 (Figure 1C, Supplementary Fig-
ure S2A, B), indicating that cleavage defects for HF Cas9
variants may vary based on target sequence.
For pLibrary cleavage assays, we observed a substan-
tial amount of nicked product, resulting from incomplete
cleavage of the target. We therefore determined the appar-
ent rate of overall cleavage (nicked and linearized prod-
uct) (Figure 1C, Supplementary Figure S2A, B, see meth-
ods section––in vitro cleavage assay and analysis). As ex-
pected, rates of pLibrary cleavage were substantially slower
than for pTargets, due to the presence of mismatches in the
target sequence (Figure 1B, C, Supplementary Figure S2A,
B). SpCas9 rapidly cleaved >50% of both negatively super-
coiled pLibraries, with the vast majority of product DNA
becoming linearized (Figure 1B, C). In contrast, for SaCas9
and HF Cas9 variants, we observed greater accumulation
of nicked plasmid, especially for pLibrary PS4 (Figure 1B,
C). On average, all other Cas9 variants accumulated sig-
nificantly more nicked product for pLibrary PS4 than Sp-
Cas9 (Figure 1D). For pLibrary EMX1, SaCas9 and Sp-
Cas9 HF1 had significantly more accumulation of nicked
product than SpCas9 (Figure 1D).
We also checked whether cleavage occurred outside of
the target region during pLibrary cleavage by testing the
cleavage activity of Cas9 against the empty plasmid back-
bone without and with the different crRNAs (Supplemen-
tary Figure S2C). The empty plasmid was minimally cleaved
by Cas9-tracrRNA:crRNA, except in the case of SpCas9-
EMX1 crRNA where a substantial nicked product was ob-
served at the three hour time point. However, we do not ob-
serve similar amounts of nicking of the pLibrary EMX1 by
Cas9 (Supplementary Figure S2C) and further analysis in-
dicated that pLibrary nicking is target-sequence dependent
(see below).
To determine which sequences were cleaved by Cas9 vari-
ants, we extracted the plasmid DNA from the supercoiled
and nicked pools, performed barcoded-PCR amplification
and multiplexed, high-throughput sequencing (HTS) to get
sufficient coverage of reads for each sample (Figure 1A,
Supplementary Figure S2D see methods section––library
preparation for HTS). Although we were unable to se-
quence the linearized pool using PCR amplicon sequenc-
ing, for our analysis, we assumed that target sequences ab-
sent from both the supercoiled and nicked pools were lin-
earized. We determined the fraction of counts for the tar-
get sequences in the HTS data and normalized this frac-
tion with the fraction of DNA present in the pool at a given
time point (Figure 1B, C) to represent an estimated abun-
dance of given target sequences within the pool (see Ma-
terials and Methods section – HTS analysis). Here, target
sequences cleaved by Cas9 were depleted from the super-
coiled pool while those nicked by Cas9 were enriched in the
nicked pool.
We initially evaluated the cumulative effects of mis-
matches on the cleavage activity of each Cas9 variant by
plotting the log-fold change in targets containing different
numbers of mismatches with the crRNA guide sequence
over time (Figure 2). We also plotted target abundance as
mismatch distribution curves (Supplementary Figure S4).
Together, the heatmaps and mismatch distribution curves
enable overall comparison of cleavage for target sequences
containing varying numbers of mismatches with the crRNA
across Cas9 variants, across time points for each Cas9 vari-
ant (Figure 2, Supplementary Figure S4). As expected, the
perfect target (zero mismatch) was rapidly depleted from the
supercoiled pool of the pLibrary (Figure 2A, B, Supplemen-
tary Figure S4A, B). SpCas9 partially cleaved sequences
with up to four mismatches in the first time point tested
for both pLibraries, as observed in previous in vitro and in
vivo studies on SpCas9 cleavage specificity (17,18) (Supple-
mentary Figure S4A, B). This observation indicates that our
in vitro pLibrary cleavage assay reproduced a similar speci-
ficity profile for SpCas9 as previous studies and can further
be used to benchmark against SaCas9 and HF Cas9 vari-
ants. Like SpCas9, SaCas9 and HF Cas9 variants cleaved
sequences containing up to four mismatches in both pLi-
braries, although the rate and extent of depletion of these
sequences varied (Figure 2A, B and Supplementary Figure
S4A, B). In general, variations in rates of depletion of mis-
matched sequences correlated with reduced rates of cleav-
age of the perfect target (Figure 2A, B), with SpCas9 HF1
and HypaCas9 showing slowest depletion of all targets in
pLibrary PS4 and SaCas9 showing slowest depletion of all
targets in pLibrary EMX1.
We also observed substantial accumulation of nicked tar-
get sequences with two to five mismatches, especially for
SaCas9 and HF Cas9 variants cleaving pLibrary PS4 (Fig-
ure 2C, D, Supplementary Figure S4C, D). These results
suggest that SaCas9 and HF Cas9 variants are slower to
fully cleave targets containing several mismatches than WT
SpCas9, resulting in formation of nicks. Notably, some tar-
get sequences with one and two mismatches were initially
nicked by SaCas9 or HF Cas9 variants, but subsequently
depleted from the nicked pool due to completion of DSB
formation (Figure 2C, D, Supplementary Figure S4C, D).
In addition, we observed differential amounts of accumula-
tion of nicked DNA for targets containing three to five mis-
matches between the two pLibraries (Figure 2C, D). Over-
all, these data suggest that Cas9 variant and crRNA se-
quence can affect the rate of second-strand cleavage at mis-
matched targets.
Prolonged exposure reduces specificity of high-fidelity Cas9
variants
Our HTS data allows us to compare the overall cleavage
efficiency and specificity of the Cas9 variants. We first de-
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Figure 2. Cas9 cleavage activity against target sequences with different mismatches in pLibrary. Log2-fold change in abundance relative to control of target
sequences containing different number of mismatches in the (A, B) supercoiled pool and (C, D) nicked pool from pLibrary (A, C) PS4 and (B, D) EMX1
when subjected to cleavage by different Cas9 variants. The time points for pLibrary cleavage are 1, 5, 30, 60 and 180 min. The color gradient represents
sequences that were depleted (red), unchanged (white), or enriched (blue) relative to the control. Values plotted represent an average of two replicates. MM
= mismatch, Sp = SpCas9, Sa = SaCas9, HF1 = SpCas9 HF1, Hypa = HypaCas9, HiFi = Alt-R® S.p. HiFi Cas9.
targets with multiple mismatches (1 to 5 MM) in the pLi-
brary (Figure 3A–D) (see Materials and Methods – HTS
analysis). Cleavage efficiencies of the perfect target within
pLibrary were similar to those observed for pTarget (Figure
1B, C, Supplementary Figure S2B). Analysis of mismatched
targets indicated differences in cleavage efficiencies in com-
parison to the perfect target (Figure 3C, D). For example,
while HiFi Cas9 cleaved the PS4 perfect target with similar
efficiency to SpCas9, we observed a marked reduction in
cleavage of PS4 mismatched targets for HiFi Cas9 (Figure
3C).
To analyze these differences in cleavage efficiencies, we
generated a specificity score that reports the relative effi-
ciency of cleavage of on- and off-target sequences over time
for the Cas9 variants relative to SpCas9 (Figure 3E, F) (see
Materials and Methods – HTS analysis). For the two WT
Cas9 orthologs, we did not observe significant differences in
specificity scores, suggesting that SpCas9 and SaCas9 have
similar specificities for the two target sequences. All three
HF Cas9 variants had some significant differences in speci-
ficity scores relative to WT SpCas9 at early time points (Fig-
ure 3E). The relative specificity scores for HF Cas9 variants
were substantially larger for pLibrary PS4 than for pLibrary
EMX1. Notably, we did not observe significant differences
in specificity scores for any Cas9 variants at later time points
(≥30 min). The lack of specificity differences between WT
and HF Cas9 at longer time points indicates that prolonged
exposure of HF Cas9 variants can eventually lead to off-
target cleavage activity.
Sequence determinants of Cas9 cleavage activity and nicking
defects
We next wanted to characterize the effects of mismatch po-
sition and type on Cas9 cleavage (Figure 3E, F). We an-
alyzed the sequences present in both the supercoiled and
nicked pools and calculated the relative abundance of target
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Figure 3. Specificity scores for Cas9 variants. (A–D) The fractions of the (A, B) perfect target and (C, D) target sequences with one to five mismatches
(MM) that were cleaved by Cas9 variants are plotted versus time for pLibrary (A, C) PS4 and (B, D) EMX1. (E, F) Specificity scores for each Cas9 variant
cleavage of pLibraries (E) PS4 and (F) EMX1 plotted relative to SpCas9 over the time course of the assay (see methods – HTS analysis). Values plotted
represent an average of two replicates. Error bars are propagation of SEM. * P < 0.05, Student’s t-test compared to SpCas9.
Materials and Methods section – HTS analysis). To visual-
ize the effects of mismatches, we used bubble heatmaps that
reveal the maximal extent of cleavage (defining bubble size)
and the rate of cleavage (defining gradient color) for targets
containing a given mismatch type at a given position of the
target.
For the supercoiled pool, target sequences that were de-
pleted over time represent sequences that can be cleaved
by Cas9. Therefore, the minimum relative abundance value
in the time course (abundancemin) represents the extent of
target sequence cleavage by Cas9 (Figure 4, Supplemen-
tary Figure S5). To estimate the rate of depletion of se-
quences from the supercoiled pool, we calculated the max-
imal change in relative abundance between time points
(max  abundance), colored as depleted (red) or unchanged
(white). For SpCas9, the heatmaps reveal cleavage defects in
the PAM-proximal ‘seed’ region for target sequences with
two to four mismatches, similar to previously reported seed
regions comprising eight to ten PAM-proximal nucleotides
(6,17,18,53,54). Seed defects for target sequences with one
mismatch were less pronounced. The higher tolerance for a
single mismatch in the seed sequence is likely due to the rela-
tively high concentration of Cas9 used for pLibrary cleavage
(18). Notably, while seed-dependent defects were evident for
other Cas9 variants (Figure 4, Supplementary Figure S5),
SpCas9 HF1 and HypaCas9 also had substantial cleavage
defects for targets containing mismatches located outside of
the seed for pLibrary PS4 (Figure 4). Mismatches located
toward the middle of PS4 (positions 11 to 13) were partic-
ularly deleterious for HypaCas9 cleaving one to three mis-
match targets, while PAM-distal mismatches as far as the
second to last position (position 19) from the PAM were
highly deleterious for SpCas9 HF1. These results suggest
that mismatches are more uniformly deleterious through-
out the target for some HF Cas9 variants, although this
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Figure 4. Sequence determinants of Cas9 cleavage activity for pLibrary PS4. Heatmaps showing the max  abundance and abundancemin of different
mismatched sequences over time for the supercoiled pool in pLibrary PS4 upon cleavage by Cas9 variants. The position of nucleotides in the targeting
region of the crRNA and the sequence are indicated on the top. The nucleotides on the left side of the heatmaps indicate the potential base pair or
mismatches formed. The crRNA-complementary nucleotides are marked by grey boxes in the heatmap which result in canonical base pairs. The PAM-
proximal ‘seed’ sequence is highlighted by the light grey box. The color gradient indicates sequences that were relatively depleted (red) or unchanged (white).
Extent of cleavage is represented as the bubble size and varies between 0 to 1. Values plotted represent an average of two replicates. MM = mismatch.
ferences in the rate and extent of cleavage, mismatch spe-
cific effects were generally very similar among all Cas9 vari-
ants. These effects were more pronounced in the seed, where
C–C or U–C mismatches were generally strongly deleteri-
ous (Figure 4, Supplementary Figure S5). In contrast, G–T
mismatches were tolerated well within the seed for all Cas9
variants. These mismatch identity observations for Cas9 are
consistent with previous in vitro library studies (6,40).
As noted above, we observed significant accumulation
of nicked plasmid for all Cas9 variants in comparison to
SpCas9 for pLibrary PS4, and for SaCas9 and Cas9 HF1
for pLibrary EMX1 (Figure 1D). This accumulation was
likely due to a defect in cleavage of the second strand fol-
lowing an initial nicking event. Our HTS data revealed that
in the nicked pool, some target sequences initially have a
high relative abundance that decreased over time, indicat-
ing the eventual formation of a DSB. In contrast, some
target sequences were initially uncleaved but accumulated
within the nicked pool over time. To visualize these effects,
we plotted the maximum abundance (abundancemax) to de-
fine the maximal extent of nicking and colored by the aver-
age change in abundance over time ( abundance) to de-
fine nicked targets that were depleted (red), accumulated
(blue), or unchanged (white) following the first time point
(Figure 5, Supplementary Figure S6). These heatmaps re-
veal that second strand cleavage defects are highly depen-
dent on mismatch position, and in some cases on mismatch
type. While some nicking defects for SaCas9 were caused by
seed mismatches, the most notable nicking defects occurred
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Figure 5. Sequence determinants of Cas9 nicking defect for pLibrary PS4. Heatmaps showing the  abundance and abundancemax of different mismatched
sequences over time for the nicked pool in pLibrary PS4 upon cleavage by Cas9 variants. The position of nucleotides in the targeting region of the crRNA
and the sequence are indicated on the top. The nucleotides on the left side of the heatmaps indicate the potential base pair or mismatches formed. The
crRNA-complementary nucleotides are marked by grey boxes in the heatmap which result in canonical base pairs. The PAM-proximal ‘seed’ sequence is
highlighted by the light grey box. The color gradient represents sequences that were depleted (red), unchanged (white), or enriched (blue) relative to the
control. The extent of nicking is represented as the bubble size and varies between 0 to 1. Values plotted represent an average of two replicates. MM =
mismatch.
target sequence (positions 9 to 12). For pLibrary PS4 tar-
gets, G–T or U–G mismatches within this region caused a
nicking defect that was severely compounded upon addi-
tion of further mismatches. For sequences with one or two
mismatches, targets containing these mismatches were ini-
tially nicked, but rapidly linearized, as visualized by large
red circles (Figure 5). However, when present within three or
four mismatch-containing targets, these mismatches caused
the target to remain nicked for prolonged periods, as vi-
sualized by large blue circles. Similar positional defects in
second-strand cleavage were observed for SaCas9 cleaving
pLibary EMX1, although the effects were less dependent
on mismatch type and less substantial than for PS4 (Figure
5, Supplementary Figure S6). Overall, these results suggest
that mismatches toward the middle of the target can reduce
second-strand cleavage by SaCas9.
For HF Cas9 variants, we observed a similar position-
specific defect in second-strand cleavage for pLibrary PS4
(Figure 5, Supplementary Figure S6). These defects were
not correlated with any particular mismatch type and ap-
peared to be dependent mainly on mismatch location. Mis-
matches located in the PAM distal region, particularly po-
sitions 11 to 16, caused strong nicking defects for all three
HF Cas9 variants for pLibrary PS4. A similar position de-
pendence was observed for EMX1 for HF Cas9 variants,
although less nicking was observed overall for this target
(Figure 1D, Supplementary Figures S4D and S5). Notably,
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percoiled DNA between SpCas9 and HiFi Cas9 (Figure 4),
the mismatch position-dependent nicking defect was sub-
stantially greater for HiFiCas9 than for SpCas9, especially
for PS4 targets containing three or four mismatches (Figure
5). This suggests that while HiFi Cas9 can cleave target se-
quences with similar numbers and types of mismatches as
the wild-type protein, accumulation of mismatches in the
PAM-distal region results in a defect in cleavage of the sec-
ond strand for HiFi Cas9 that is not observed for the wild-
type protein.
Closely spaced mismatches compound overall and second-
strand cleavage defects
For sequences containing multiple mismatches, it has pre-
viously been observed that the distance between mis-
matches can affect the level of cleavage defect by SpCas9
(6,14,17,18,38,39,55). We wished to determine the extent
to which mismatch separation affects cleavage by all five
Cas9 variants, as well as whether distance between mis-
matches influenced second-strand cleavage defects. We an-
alyzed sequences containing two mismatches, which were
highly represented in our target libraries (Supplementary
Figure S1C). In a 20-nucleotide sequence, two mismatches
can be separated by between 0 (i.e. mismatches located at
adjacent positions) and 18 nucleotides (i.e. mismatches lo-
cated at the beginning and end of the sequence). To deter-
mine how this distance affects the rate of cleavage for the
Cas9 variants, we analyzed the supercoiled and nicked pool
using bubble heatmaps as described above, but now based
on the distance between the two mismatches and the loca-
tion of the two mismatches.
Double mismatches spaced close together (zero to four
nucleotides separation) caused substantial decrease in de-
pletion from the supercoiled pool, consistent with previ-
ous reports that closely spaced mismatches are deleterious
for Cas9-dependent cleavage (17,18,38) (Figure 6A, B). One
exception was SaCas9, which did not display a defect for
closely spaced double mismatches for pLibrary PS4 (Figure
6A), although this defect was apparent for pLibrary EMX1
(Figure 6B). Conversely, SpCas9 HF1 displayed substantial
cleavage defects for double mismatches spaced further apart
(14 to 17 nucleotides separation) for PS4 (Figure 6A), a de-
fect that was not observed for EMX1 (Figure 6B). These
results underscore the variability in mismatch effects based
on target sequence. To determine whether the effect of mis-
match spacing is also influenced by the position within the
target, we analyzed the effects of two mismatches sepa-
rated by between zero and eight nucleotides within the seed
or PAM-distal region (Figure 6C, D). Closely spaced mis-
matches (five or fewer nucleotides separation) were highly
deleterious in the seed. In contrast, mismatch spacing had
little impact in the PAM-distal region, where mismatches
separated by any distance were similarly tolerated.
For the nicked pool, double mismatches caused simi-
lar amounts of nicking defects regardless of spacing across
the whole target, as visualized by bubbles of similar sizes
(Figure 6E, F). However, the rate of nicking or lineariza-
tion of targets was impacted to some degree by mismatch
distance. This is especially apparent for SaCas9 and HiFi
Cas9 cleaving pLibrary PS4 (Figure 6E). While most dou-
ble mismatches led to eventual linearization by SaCas9 and
HiFi Cas9, as visualized by bubbles with shades of red or
white, mismatches spaced 13 to 16 nucleotides apart were
shades of blue, indicating accumulation of these targets in
the nicked fraction due to a stronger nicking defect. Mis-
matches with this spacing necessarily places one mismatch
within the PAM-distal region, consistent with the position-
dependent nicking defect described above (Figure 5, Sup-
plementary Figure S6). Further analysis of mismatch dis-
tance in the PAM-distal region revealed marked distance-
dependent effects (Figure 6G, H). In general, for SaCas9
and HF Cas9 variants, mismatches spaced closer together
in the PAM-distal region caused second-strand cleavage de-
fects and accumulation in the nicked pool for pLibrary PS4
(Figure 6G). Double mismatches separated by four or fewer
nucleotides in the PAM-distal region were especially delete-
rious for SpCas9 HF1 and HypaCas9 (Figure 6G). A simi-
lar defect for closely spaced double mismatches in the PAM-
distal region was observed for SpCas9 HF1 for pLibrary
EMX1, although the extent of the defect was less substan-
tial (Figure 6H). For SaCas9 cleaving pLibrary PS4, mis-
matches spaced further apart (six to eight nucleotides) in
either region caused a partial defect in second-strand cleav-
age resulting in delayed linearization, as visualized by large
white or red bubbles (Figure 6G). Overall, these results in-
dicate that multiple closely spaced mismatches within the
PAM-distal region can cause reduced rates of second-strand
cleavage for SaCas9 and HF Cas9 variants, albeit in a
target-dependent manner.
Validating nicking defects against mismatched targets
Finally, to validate the nicking defect observed in pLibrary
cleavage, we verified cleavage of individual target sequences
containing two to five mismatches that were present in the
nicked pool of pLibrary PS4 at the longest time point (three
hours). Targets were subjected to cleavage by each Cas9
variant (Figure 7A) and the extent of nicking and lineariza-
tion was quantified at 10 min and 3 h (Figure 7B). All Cas9
variants linearized targets with two or three mismatches af-
ter three hours of incubation. We observed small but sig-
nificant differences in nicking and linearization between
SpCas9 and other Cas9 variants for targets with two or
three mismatches. The nicking defect was most notable for
SaCas9 cleaving a target containing three mismatches in
comparison to SpCas9, which mostly linearized this target.
For targets with more than three mismatches, we observed
substantially less linearization for all Cas9 variants. A tar-
get containing four mismatches within the seed (pTarget 4.1
MM) caused the strongest defect in any type of cleavage, al-
though both SpCas9 and SaCas9 nicked 30 to 40% of the
target by 3 h. Cleavage was significantly lower for all three
HF Cas9 variants for this target. In contrast, all Cas9 vari-
ants cleaved target sequences with four or five mismatches
in the PAM-distal region (pTarget 4.2 MM and 5 MM).
As expected, based on our HTS analysis, these targets were
nicked substantially but not linearized, indicating a second-
strand cleavage defect. For pTarget 4.2 MM, SaCas9, Hy-
paCas9 and HiFi Cas9 had significantly more nicked prod-
uct and significantly less linearized product that SpCas9, in-
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Figure 6. Effect of double mismatches in the target sequence on Cas9 cleavage activity. Heatmaps plotting the max  abundance and abundancemin or 
abundance and abundancemax for target sequences with two mismatches in the (A–D) supercoiled pools and (E–H) nicked pools, respectively. Heatmaps
show the effect of two mismatches as a function of distance between the two mismatches (A, B, E, F) across the whole target sequence or (C, D, G, H) in
the seed or PAM-distal regions over time upon cleavage by Cas9 variants. The  max change or  abundance scale for supercoiled and nicked pools are
indicated on the top. Abundancemin and abundancemax are represented as the bubble size and varies between 0 to 1. Values plotted represent an average of
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Figure 7. Cas9 variants have different cleavage activities against mismatched targets. (A) Representative agarose gels showing cleavage of a negatively
supercoiled (nSC) plasmid containing the perfect target (0 MM) or mismatched (2 to 5 MM) target over a time course by Cas9 variants, resulting in linear
(li) and/or nicked (n) products. Time points at which the samples were collected are 15 s, 30 s, 1 min, 2 min, 5 min, 15 min, 30 min, 1 h, 3 h and 5 h.
tr:crRNA = tracrRNA:crRNA. All controls were performed under the same conditions as the longest time point for the experimental samples. Controls:
(–) = pTarget or pLibrary alone incubated at 37◦C for the longest time point in the assay (5 h); (-cr) = pTarget or pLibrary incubated with Cas9 only at
37◦C for the longest time point in the assay (5 h); n = Nt.BspQI nicked pUC19; li = BsaI-HF linearized pUC19. (B) Quantification of supercoiled, linear
and nicked pools from cleavage of perfect or fully crRNA-complementary (0 MM) and mismatched (2 to 5 MM) target plasmid by Cas9 after 10 min and 3
h. pTarget MM indicates target plasmid (0, 2 to 5 MM) alone incubated at 37◦C for the time points indicated. Target sequences tested are listed with PAM
(bold) and mismatches (lowercase and red) indicated. (–) indicates a cleavage reaction with the target plasmid and Cas9 only, and (+) indicates a cleavage
reaction with the target plasmid, Cas9 and cognate tracrRNA:crRNA. Values plotted represent an average of three replicates. Error bars are SEM. * or •
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trast, SpCas9 accumulated significantly more nicked prod-
uct than SaCas9, SpCas9 HF1 and HiFi Cas9 by 3 h for
pTarget 5 MM, consistent with the overall lower specificity
of SpCas9. Overall, these results validate stronger nicking
and overall cleavage defects of SaCas9 and HF Cas9 vari-
ants in comparison to SpCas9 for the PS4 target.
DISCUSSION
Cas9 specificity has been the subject of substantial in-
vestigation and engineering efforts, due to its importance
for genome editing technologies (6,16–18,25,27,31,35,39–
41). However, many previous studies investigated individ-
ual Cas9 variants separately, focusing on target binding
and/or DSB formation by Cas9. Our in vitro library cleav-
age assay has enabled a comparative study of the cleavage
specificity of Cas9 variants, revealing cleavage defects that
have previously remained undetected (6,14,15,38,40,52). We
find that engineered SpCas9 variants display higher speci-
ficity than wild-type SpCas9 in a target-dependent man-
ner, although prolonged exposure reduces this specificity.
Over time, all Cas9 variants can cleave sequences with up
to five mismatches. However, while SpCas9 linearizes most
target sequences with multiple mismatches as previously
observed, SaCas9 and HF Cas9 variants often only nick
these sequences. It is well established that Cas9 binds to se-
quences with limited similarity to the crRNA, although it
has generally been concluded that cleavage may not occur
at these sites (6,40,56–58). Our results now reveal that par-
tial cleavage can occur at off-target sites, although second-
strand cleavage defects prevent DSB formation. Most pre-
vious specificity studies tested for DSB and/or indel forma-
tion at target and off-target sites (6,25,27,31,35,39,40). Al-
though nicked DNA may be subject to error-prone DNA re-
pair or lead to collapse of replisomes and potential mutage-
nesis (59–63), nicks may also be repaired by error-free DNA
repair pathways. Thus, nicking defects may obscure cleav-
age that does occur at off-target sites, resulting in higher
genome editing specificity for SaCas9 and HF Cas9 vari-
ants.
Recent studies have compared the binding and cleav-
age specificities of SpCas9 and HF Cas9 variants, includ-
ing Cas9 HF1 and HypaCas9 (6,52,64,65). Although target
binding defects were not observed for these variants, PAM-
distal mismatches decreased the rate of cleavage for both
variants in comparison to SpCas9. Our results reveal that
PAM-distal mismatches not only slow the rate of overall
cleavage but can also slow the rate of DSB formation for
SaCas9 and HF Cas9 variants, leading to nick formation.
This second-strand cleavage defect may be due to R-loop
collapse and premature target release following nicking of
one of the strands, as has been proposed for the overall
decreased kinetics of off-target cleavage by HF Cas9 vari-
ants (6,52). Additional defects may be caused by decreased
movement of the HNH domain, which is required for cleav-
age activation of both the HNH and RuvC catalytic do-
mains (4,27,28,66–68). Single-molecule studies of SpCas9
HF1 and HypaCas9 revealed that HNH domain move-
ments were diminished in comparison to wild-type SpCas9,
especially in the presence of PAM-distal mismatches (27).
Together with our observation of nicking defects caused
by PAM-distal mismatches, this suggests that cleavage by
the HNH domain is impaired upon binding to targets with
PAM-distal mismatches due to loss of domain rearrange-
ments necessary to position the HNH active site for cleav-
age. However, sufficient HNH domain movement may oc-
cur to trigger cleavage of the non-target strand by the RuvC
domain, leading to nicking of the non-target strand.
The natural role of Cas effectors is to provide defense
against invading genetic elements. Specificity of these effec-
tors has likely been tuned through evolutionary pressures
exerted by rapidly evolving phages and other mobile ge-
netic elements. Thus, it is surprising that natural orthologs
of Cas effectors, including SaCas9 and various Cas12a or-
thologs, have been shown to have higher intrinsic genome
editing specificity than SpCas9 (21,23,69–71). In vitro in-
vestigations have been vital for defining the native cleavage
specificities of these nucleases to understand their natural
role as immune effectors. We and others have observed that
Cas9 and Cas12a have similar PAM-distal mismatch toler-
ance and similar defects for C mismatches and tolerances
of T mismatch (6,42). These findings are consistent with
the observation that mismatch position impacts the abil-
ity of phages to escape immunity (10,11,13), and suggest
that the types of mutations that arise may be similarly con-
sequential. We also previously observed that Cas12a, like
SaCas9 and HF Cas9 variants, can cleave sequences with
several mismatches, but displays a second-strand cleavage
defect in the presence of multiple PAM-distal mismatches
(42). The ability to nick target sequences with multiple mis-
matches may allow broader immunity against phages, as
nicking within mutated target regions may reduce the rate
of phage replication and could still enable target degrada-
tion by host nucleases (10,72). Non-specific nicking activ-
ities have also been reported for several Cas effector pro-
teins (42,72,73), suggesting that DNA nicking is part of the
vast repertoire of nucleic acid cleavage activities employed
by CRISPR-Cas systems to neutralize phage infection. Fu-
ture studies may determine whether single-strand breaks
in the invading phage genome are sufficient for CRISPR-
mediated immunity.
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